Hypertriglyceridemia

Elevated Triglyceride Levels Affect Glycemic Control in Type 2 Diabetes

Elevated Triglyceride Levels Affect Glycemic Control in Type 2 Diabetes

By

Reducing triglyceride levels in patients with type 2 diabetes may help them attain more optimal glycemic control.

Omega-3 Fatty Acids Reduce Major CV Events in Mild Hypertriglyceridemia

Omega-3 Fatty Acids Reduce Major CV Events in Mild Hypertriglyceridemia

By

In high-risk patients with mild hypertriglyceridemia, omega-3 fatty acids improved triglyceride levels and reduced major adverse cardiovascular events, according to a new meta-analysis.

Icosapent Ethyl Reduces Ischemic Event Risk in Patients With Hypertriglyceridemia Despite Statin Use

Icosapent Ethyl Reduces Ischemic Event Risk in Patients With Hypertriglyceridemia Despite Statin Use

By

The risk for the primary composite endpoint was significantly lowered by 25% among patients who received 2g of icosapent ethyl twice daily vs those who received placebo.

Hyperglycemia, Obesity, Hypertriglyceridemia Negatively Related to CAN in T2D

Hyperglycemia, Obesity, Hypertriglyceridemia Negatively Related to CAN in T2D

By

Hyperglycemia, obesity, and hypertriglyceridemia in type 2 diabetes are negatively related to indices of cardiovascular autonomic neuropathy.

No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia

No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia

By

Statins were associated with a reduction in mortality but there was no significant difference in the composite end point with fenofibrates alone or in combination with statins.

LDL Cholesterol, Triglyceride Reductions in Hypertriglyceridemia Vary by Statin

LDL Cholesterol, Triglyceride Reductions in Hypertriglyceridemia Vary by Statin

Greater LDL cholesterol reductions for rosuvastatin 10 mg to 40 mg vs equal and double doses of atorvastatin and simvastatin.

Sign Up for Free e-Newsletters



CME Focus